Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

December 19, 2024 6:15 AM 2 min read

Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

by Avi Kapoor Benzinga Staff Writer

Follow

Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) rose sharply in today's pre-market trading.

Astellas and Sangamo Therapeutics disclosed Capsid license agreement to deliver genomic medicines for neurological diseases.

Sangamo Therapeutics shares jumped 19.5% to $2.81 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

Losers

Now Read This:

Top 3 Tech And Telecom Stocks That May Crash This Month

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Posted In:

News Pre-Market Outlook Markets Movers Trading Ideas Losers

AEMDAethlon Medical Inc

APCXAppTech Payments Corp

CURRCurrenc Group Inc

DSGNDesign Therapeutics Inc

ELABPMGC Holdings Inc

KULRKULR Technology Group Inc

Not Available-%

LITMSnow Lake Resources Ltd

LWLamb Weston Holdings Inc

MESOMesoblast Ltd

MUMicron Technology Inc

NVNINvni Group Ltd

PTPIPetros Pharmaceuticals Inc

QNTMQuantum BioPharma Ltd

SGMOSangamo Therapeutics Inc

SLXNSilexion Therapeutics Corp

VRAXVirax Biolabs Group Ltd

XHGXChange Tec Inc

CURRENC Group Inc. (NASDAQ:CURR) gained 219.5% to $6.39 in pre-market trading after jumping 54% on Wednesday.
XChange TEC.INC (NASDAQ:XHG) climbed 170% to $2.13 in pre-market trading after declining over 50% on Wednesday.
AppTech Payments Corp. (NASDAQ:APCX) gained 170% to $1.03 in pre-market trading.
Silexion Therapeutics Corp (NASDAQ:SLXN) gained 68% to $3.55 in pre-market trading after dropping 26% on Wednesday.
Mesoblast Limited (NASDAQ:MESO) rose 44.5% to $17.70 in pre-market trading. Mesoblast’s RYONCIL became the first FDA-approved mesenchymal stromal cell therapy in the U.S.
Elevai Labs Inc. (NASDAQ:ELAB) gained 38.6% to $2.98 in pre-market trading after gaining 9% on Wednesday.
Dallasnews Corp (NASDAQ:DALN) gained 38% to $6.72 in pre-market trading after falling 5% on Wednesday.
KULR Technology Group, Inc. (NASDAQ:KULR) rose 28% to $2.68 in pre-market trading after jumping 44% on Wednesday.
XCHG Limited (NASDAQ:XCH) gained 24.2% to $2.67 in pre-market trading after dipping more than 90% on Wednesday.

Snow Lake Resources Ltd. (NASDAQ:LITM) shares tumbled 40.5% to $0.4847 in pre-market trading after jumping 348% on Wednesday.
Aethlon Medical, Inc. (NASDAQ:AEMD) declined 36.4% to $0.42 in pre-market trading after jumping more than 80% on Wednesday.
Abacus Life, Inc. (NASDAQ:ABL) shares fell 20.5% to $6.00 in pre-market trading.
Lamb Weston Holdings, Inc. (NYSE:LW) shares dipped 18.6% to $63.50 in pre-market trading as the company posted downbeat quarterly results and lowered FY25 outlook.
Nvni Group Limited (NASDAQ:NVNI) fell 18.5% to $0.5213 in today's pre-market trading after jumping 52% on Wednesday.
Micron Technology, Inc. (NASDAQ:MU) dipped 15.6% to $87.60 in pre-market trading. Micron posted better-than-expected earnings for its first quarter, while sales missed expectations. The company said it sees second-quarter revenue of $7.9 billion, plus or minus $200 million, versus estimates of $9 billion. The company expects second-quarter adjusted earnings of $1.43 per share, plus or minus 10 cents per share, versus estimates of $1.92 per share.
Virax Biolabs Group Limited (NASDAQ:VRAX) fell 15.6% to $2.00 in pre-market trading after surging 39% on Wednesday.
Quantum BioPharma Ltd. (NASDAQ:QNTM) shares fell 14.5% to $2.95 in pre-market trading after dipping 18% on Wednesday.
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 14.3% to $0.3008 in pre-market trading following a 30% plunge on Wednesday.
Design Therapeutics, Inc. (NASDAQ:DSGN) fell 14.2% to $5.10 in pre-market trading after declining 5% on Wednesday.

AEMDAethlon Medical Inc

APCXAppTech Payments Corp

CURRCurrenc Group Inc

DSGNDesign Therapeutics Inc

ELABPMGC Holdings Inc

KULRKULR Technology Group Inc

Not Available-%

LITMSnow Lake Resources Ltd

LWLamb Weston Holdings Inc

MESOMesoblast Ltd

MUMicron Technology Inc

NVNINvni Group Ltd

PTPIPetros Pharmaceuticals Inc

QNTMQuantum BioPharma Ltd

SGMOSangamo Therapeutics Inc

SLXNSilexion Therapeutics Corp

VRAXVirax Biolabs Group Ltd

XHGXChange Tec Inc

Comments

Loading...